Literature DB >> 18582948

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Cyrus A Raji1, James T Becker, Nicholas D Tsopelas, Julie C Price, Chester A Mathis, Judith A Saxton, Brian J Lopresti, Jessica A Hoge, Scott K Ziolko, Steven T DeKosky, William E Klunk.   

Abstract

We evaluated the region-to-region correlation, laterality and asymmetry of amyloid deposition in subjects with mild cognitive impairment (MCI) or Alzheimer's disease (AD) using the amyloid tracer, Pittsburgh Compound B (PiB). Seventeen subjects, including 7 with MCI (MMSE 26.7+/-2.4) and 10 with AD (MMSE of 24.8+/-2.7) underwent PiB imaging. Measures of laterality (i.e., group-wise predilection for right or left) and asymmetry (i.e., group-wise predilection for unequal PiB retention between the two hemispheres) were calculated for 17 Regions of Interest (ROIs). Regional correlations were calculated along with within-group and between-groups statistical analyses of laterality and asymmetry metrics. The median correlation between PiB retention across all pairs of ROIs was 0.65, with highest correlations found in areas of highest PiB retention (r=0.74). Overall, PiB retention was symmetric bilaterally, but there was PiB laterality in MCI in dorsal frontal cortex [(t(6)=3.05, p=0.02, L>R] and sensory-motor area [t(6)=3.10, p=0.02, L>R] and in AD in the occipital pole (t(9)=-2.63, p=0.03, R>L). The most significant asymmetries in PiB retention were found in sub-cortical white matter (t(6)=3.99, p=0.01) and middle precuneus [(t(6)=3.57, p=0.01] in MCI, and in lateral temporal cortex (t(9)=3.02, p=0.01) and anterior ventral striatum [t(9)=2.37, p=0.04] in AD. No group differences (AD versus MCI) were detected in laterality [F (1, 15)=0.15, p=0.7] or asymmetry [F (1, 15)=0.7, p=0.42].

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582948      PMCID: PMC2501111          DOI: 10.1016/j.jneumeth.2008.05.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  21 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

Authors:  William E Klunk; Brian J Lopresti; Milos D Ikonomovic; Iliya M Lefterov; Radosveta P Koldamova; Eric E Abrahamson; Manik L Debnath; Daniel P Holt; Guo-feng Huang; Li Shao; Steven T DeKosky; Julie C Price; Chester A Mathis
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

3.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Authors:  Brian J Lopresti; William E Klunk; Chester A Mathis; Jessica A Hoge; Scott K Ziolko; Xueling Lu; Carolyn C Meltzer; Kurt Schimmel; Nicholas D Tsopelas; Steven T DeKosky; Julie C Price
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

Review 4.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

5.  MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution.

Authors:  C C Meltzer; J K Zubieta; J M Links; P Brakeman; M J Stumpf; J J Frost
Journal:  J Cereb Blood Flow Metab       Date:  1996-07       Impact factor: 6.200

Review 6.  Clinical diagnosis and management of Alzheimer's disease.

Authors:  Mustafa M Husain; Robert K Garrett
Journal:  Neuroimaging Clin N Am       Date:  2005-11       Impact factor: 2.264

7.  Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

Authors:  Julie C Price; William E Klunk; Brian J Lopresti; Xueling Lu; Jessica A Hoge; Scott K Ziolko; Daniel P Holt; Carolyn C Meltzer; Steven T DeKosky; Chester A Mathis
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

9.  Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Authors:  S S Mirra; M Gearing; D W McKeel; B J Crain; J P Hughes; G van Belle; A Heyman
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

10.  Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

Authors:  C C Meltzer; J P Leal; H S Mayberg; H N Wagner; J J Frost
Journal:  J Comput Assist Tomogr       Date:  1990 Jul-Aug       Impact factor: 1.826

View more
  33 in total

Review 1.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.

Authors:  D P Devanand; Arthur Mikhno; Gregory H Pelton; Katrina Cuasay; Gnanavalli Pradhaban; J S Dileep Kumar; Neil Upton; Robert Lai; Roger N Gunn; V Libri; Xinhua Liu; Ronald van Heertum; J John Mann; Ramin V Parsey
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-04-29       Impact factor: 2.680

3.  The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults.

Authors:  Patrizia Vannini; Trey Hedden; Willem Huijbers; Andrew Ward; Keith A Johnson; Reisa A Sperling
Journal:  Cereb Cortex       Date:  2012-05-14       Impact factor: 5.357

4.  Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.

Authors:  Edmond Teng; Nicole Chow; Kristy S Hwang; Paul M Thompson; Karen H Gylys; Gregory M Cole; Clifford R Jack; Leslie M Shaw; John Q Trojanowski; Holly D Soares; Michael W Weiner; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2014-12-24       Impact factor: 2.959

5.  The default mode network and related right hemisphere structures may be the key substrates of dementia.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients.

Authors:  Dean F Wong; Abhay R Moghekar; Daniele Rigamonti; James R Brašić; Olivier Rousset; William Willis; Chris Buckley; Adrian Smith; Beril Gok; Paul Sherwin; Igor D Grachev
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

7.  Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.

Authors:  Nancy J Donovan; Joseph J Locascio; Gad A Marshall; Jennifer Gatchel; Bernard J Hanseeuw; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Am J Psychiatry       Date:  2018-01-12       Impact factor: 18.112

8.  Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.

Authors:  Thomas G Beach; Lucia I Sue; Douglas G Walker; Marwan N Sabbagh; Geidy Serrano; Brittany N Dugger; Monica Mariner; Kim Yantos; Jonette Henry-Watson; Glenn Chiarolanza; Jose A Hidalgo; Leslie Souders
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 9.  Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Authors:  G D Rabinovici; W J Jagust
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

10.  Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Authors:  Ann D Cohen; Julie C Price; Lisa A Weissfeld; Jeffrey James; Bedda L Rosario; Wenzhu Bi; Robert D Nebes; Judith A Saxton; Beth E Snitz; Howard A Aizenstein; David A Wolk; Steven T Dekosky; Chester A Mathis; William E Klunk
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.